Author

Sara E. Barnato

Observed names: Barnato, Sara E., S. Barnato, Sara Barnato, Sara E Barnato

Institution: Northwestern University

Observed institutions: Northwestern University, Endeavor Health, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

OpenAlex ID: A5067764177

Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A 20-Year Review from the Southern Network on Adverse Reactions (SONAR)

2012 · Sony Jacob, Brianne Dunn, et al. · Seminars in Thrombosis and Hemostasis · 89

The role of targeted therapy and biomarkers in breast cancer treatment

2012 · Alison T. Stopeck, Ursa Brown-Glaberman, et al. · Clinical & Experimental Metastasis · 45

Association Between Pharmaceutical Support and Basic Science Research on Erythropoiesis-Stimulating Agents

2010 · Charles L. Bennett, Stephen Y. Lai, et al. · Archives of Internal Medicine · 24

Advances in renal bone disease: Osteoporosis and chronic kidney disease

2009 · Sara Barnato, Stuart M. Sprague · Current Rheumatology Reports · 7

Serious Adverse Drug Reactions (sADRS) Associated with Hematopoietic Growth Factors: A Systematic Review From the Southern Network on Adverse Reactions (SONAR) Program

2010 · LeAnn Norris, Zaina Qureshi, et al. · Blood · 4

Phase II neoadjuvant trial with carboplatin and eribulin mesylate in patients with triple-negative breast cancer.

2012 · Sara E. Barnato, Jacqueline Sara Jeruss, et al. · Journal of Clinical Oncology · 3

Biological Subtypes of Breast Cancer

2015 · Sara E. Barnato, William J. Gradishar · Medical radiology · 2

A national survey on oncology clinicians’ recommendations and knowledge of contraception for women with cancer

2013 · S. York, S. Barnato, et al. · Contraception · 1

Effect of targeted therapy on circulating tumor cells in patients with metastatic breast cancer.

2012 · Antonio Giordano, Sara E. Barnato, et al. · Journal of Clinical Oncology

Evaluating Mortality with Erythropoietin Stimulating Agents (ESAs) in the Oncology Setting: The Importance of Selecting Trials That Include Survival or Loco-Regional Tumor Control as a Primary Endpoint

2008 · Athena T Samaras, Sara E Barnato, et al. · Blood

Evaluation of Conflicts of Interest in Basic Science Studies Evaluating Erythropoietin and Erythropoietin Effects of Solid Cancer Cell Lines

2008 · Sara E Barnato, Simone N Boyle, et al. · Blood

Evaluating Mortality with Erythropoietic Stimulating Agents (ESAs) in the Nephrology Setting: The Distinction between Evaluating Trials That Measure Survival as a Primary or Secondary Efficacy Endpoint Versus a Safety Endpoint.

2007 · Sara E. Barnato, Charles L. Bennett, et al. · Blood

Works count: 13

Citation count: 175

H-index: 4

I10-index: 3